Stabilized topical acidic fibroblast growth factor formulation

Details Stabilized topical acidic fibroblast growth factor formulation Stabilized topical acidic fibroblast growth factor formulation

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61K 47/18 (2006.01) A61K 47/36 (2006.01) A61K 47/38 (2006.01) A61L 26/00 (2006.01)

Patent

CA 2080537

JLT31 18554 TITLE OF THE INVENTION STABILIZED TOPICAL ACIDIC FIBROBLAST GROWTH FACTOR FORMULATION ABSTRACT THE INVENTION A sterile aqueous medicinal composition containing acidic fibroblast growth factor combined with an amount of heparin sufficient to stabilize acidic fibroblast growth factor, with said acidic fibroblast growth factor and heparin combined with a sufficient amount of hydroxyethyl cellulose to form a viscous solution which when dried forms a film, with said acidic fibroblast growth factor, heparin and hydroxyethyl cellulose combined with a chelating agent capable of stabilizing the composition at temperatures higher that 4° C.

Affiliated with

Also associated with

Rating

Stabilized topical acidic fibroblast growth factor formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Stabilized topical acidic fibroblast growth factor formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized topical acidic fibroblast growth factor formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1448352